Immune response to two different dosing schedules of the anthrax vaccine precipitated (AVP) vaccine (Q80553894)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17604880%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

Immune response to two different dosing schedules of the anthrax vaccine precipitated (AVP) vaccine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17604880%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17604880%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Les Baillie

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17604880%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Matthew J Hepburn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17604880%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

E Hugh Dyson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17604880%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Karen E Brenneman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17604880%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Nicola Bailey

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17604880%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Lucy Wilkinson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17604880%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Rebecca Hornby

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17604880%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Alfred J Mateczun

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17604880%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Matthew G Bell

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17604880%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

4 June 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17604880%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17604880%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17604880%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17604880%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

6089-6097

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17604880%20AND%20SRC:MED&resulttype=core&format=json

Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense

1 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.018

Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.018

Anthrax as a biological weapon, 2002: updated recommendations for management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.018

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.018

In vitro correlate of immunity in an animal model of inhalational anthrax

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.018

In vitro correlate of immunity in a rabbit model of inhalational anthrax

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.018

Search for correlates of protective immunity conferred by anthrax vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.018

Comparative safety and efficacy against Bacillus anthracis of protective antigen and live vaccines in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.018

Characterization of the human immune response to the UK anthrax vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.018

Anthrax vaccine: evidence for safety and efficacy against inhalational anthrax

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.018

Anthrax vaccine: increasing intervals between the first two doses enhances antibody response in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.018

Anthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.018

Mass value assignment of total and subclass immunoglobulin G in a human standard anthrax reference serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.018

Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.018

The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.018

Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.018

Genetic immunization against anthrax

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.018

DNA vaccines against anthrax

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.018

Monitoring of ELISA-reactive antibodies against anthrax protective antigen (PA), lethal factor (LF), and toxin-neutralising antibodies in serum of individuals vaccinated against anthrax with the PA-based UK anthrax vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.018

Contribution of immunological memory to protective immunity conferred by a Bacillus anthracis protective antigen-based vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.018

Anthrax post-vaccinal cell-mediated immunity in humans: kinetics pattern

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.018

10.1016/J.VACCINE.2007.05.018

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17604880%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference